BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23808295)

  • 1. [Intraosseous blocks in the treatment of symmetrical distal diabetic polyneuropathy].
    Sokov EL; Kornilova LE; Artiukov OP
    Ter Arkh; 2013; 85(4):61-5. PubMed ID: 23808295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
    Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
    Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain.
    Dworkin RH; Jensen MP; Gammaitoni AR; Olaleye DO; Galer BS
    J Pain; 2007 Feb; 8(2):118-26. PubMed ID: 16949878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The complex treatment of the pain syndrome in diabetic distal polyneuropathy using intraosteal blockades].
    Sokov EL; Arsiukhin NA; Kornilova LE; Nozdriukhina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):72-5. PubMed ID: 23096049
    [No Abstract]   [Full Text] [Related]  

  • 5. High doses of topical amitriptyline in neuropathic pain: two cases and literature review.
    Kopsky DJ; Hesselink JM
    Pain Pract; 2012 Feb; 12(2):148-53. PubMed ID: 21676162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy.
    Guastella V; Mick G
    Diabetes Metab; 2009 Feb; 35(1):12-9. PubMed ID: 19046917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy.
    Spallone V; Morganti R; D'Amato C; Greco C; Cacciotti L; Marfia GA
    Diabet Med; 2012 May; 29(5):578-85. PubMed ID: 22023377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
    Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
    Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient perceptions associated with the 5% lidocaine medicated plaster in daily practice.
    Überall MA; Müller-Schwefe GH
    Curr Med Res Opin; 2012 Jun; 28(6):901-9. PubMed ID: 22506624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.
    Kadiroglu AK; Sit D; Kayabasi H; Tuzcu AK; Tasdemir N; Yilmaz ME
    J Diabetes Complications; 2008; 22(4):241-5. PubMed ID: 18413214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence, clinical features and management of periphral neuropathy among diabetic patients in Tikur Anbessa and St. Paul's Specialized University Hospitals, Addis Ababa, Ethiopia.
    Jarso G; Ahmed A; Feleke Y
    Ethiop Med J; 2011 Oct; 49(4):299-311. PubMed ID: 23409395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study.
    Lynch ME; Clark AJ; Sawynok J; Sullivan MJ
    J Pain; 2005 Oct; 6(10):644-9. PubMed ID: 16202956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The intensity of neuropathic pain and the severity of insomnia in diabetic polyneuropathy].
    Mandra EV; Parfenov VA; Akhmedzhanova LT; Fadeev VV; Amosova MV; Popovskaya KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(5. Vyp. 2):87-92. PubMed ID: 38934671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous lidocaine on manifestations of fibromyalgia.
    Vlainich R; Issy AM; Gerola LR; Sakata RK
    Pain Pract; 2010; 10(4):301-5. PubMed ID: 20230454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs].
    Bregovskiĭ VB; Posokhina OV; Karpova IA
    Ter Arkh; 2005; 77(10):15-9. PubMed ID: 16320678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.
    Herrmann DN; Pannoni V; Barbano RL; Pennella-Vaughan J; Dworkin RH
    Muscle Nerve; 2006 Jan; 33(1):42-8. PubMed ID: 16228968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.
    Biesbroeck R; Bril V; Hollander P; Kabadi U; Schwartz S; Singh SP; Ward WK; Bernstein JE
    Adv Ther; 1995; 12(2):111-20. PubMed ID: 10150323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depressive symptoms and quality of life in type 2 diabetic patients with diabetic distal polyneuropathy].
    Moreira RO; Amâncio AP; Brum HR; Vasconcelos DL; Nascimento GF
    Arq Bras Endocrinol Metabol; 2009 Dec; 53(9):1103-11. PubMed ID: 20126868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.